跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TELNASAL ALLERGY SPRAY mometasone furoate (as monohydrate) 50 mcg/actuation suspension spray bottle - TGA Drug Approval Details
Approvals
/
TGA
/
TELNASAL ALLERGY SPRAY mometasone furoate (as monohydrate) 50 mcg/actuation suspension spray bottle
Approved
STANDARD
TELNASAL ALLERGY SPRAY mometasone furoate (as monohydrate) 50 mcg/actuation suspension spray bottle
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
bd8d09e341414f4e
Company
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Type
Standard
Approval Details
Approval Id
bd8d09e341414f4e
Product Name
TELNASAL ALLERGY SPRAY mometasone furoate (as monohydrate) 50 mcg/actuation suspension spray bottle
Artg Id
330202
Artg Name
TELNASAL ALLERGY SPRAY mometasone furoate (as monohydrate) 50 mcg/actuation suspension spray bottle
Sponsor
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Company Detail Path
/organization/sanofi-aventis-healthcare-pty-ltd
Artg Date
2020-02-20
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/159f92d3e32ae12b72252e65e91d02e5.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/74bb004758cbadce273dd522636f784e.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
bd8d09e341414f4e
Type
Standard
Back to TGA Approvals